S
Sheila K. Singh
Researcher at McMaster University
Publications - 180
Citations - 17443
Sheila K. Singh is an academic researcher from McMaster University. The author has contributed to research in topics: Stem cell & Population. The author has an hindex of 33, co-authored 141 publications receiving 15654 citations. Previous affiliations of Sheila K. Singh include Hamilton Health Sciences & McMaster Children's Hospital.
Papers
More filters
Journal ArticleDOI
Progression of atypical extraventricular neurocytoma to anaplastic ganglioglioma.
Daniel Rusiecki,Boleslaw Lach,Branavan Manoranjan,Adam Fleming,Olufemi Ajani,Sheila K. Singh +5 more
TL;DR: Tumor transformation was associated with overexpression of components of the sonic hedgehog and Wnt developmental signaling pathways, which are known to regulate tumor-initiating cells in malignant brain neoplasms.
Journal ArticleDOI
The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review.
K.W. Wang,K.W. Wang,R. Chau,R. Chau,Adam Fleming,Adam Fleming,Laura Banfield,Sheila K. Singh,Sheila K. Singh,Donna L. Johnston,Shayna Zelcer,Shahrad Rod Rassekh,Sarah Burrow,Marlie Valencia,Marlie Valencia,R. J. de Souza,Lehana Thabane,M. C. Samaan,M. C. Samaan +18 more
TL;DR: Current evidence for the presence of interventions to manage obesity, including hypothalamic obesity, in SCBT is summarized.
Journal ArticleDOI
RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status
Asha Sinha,Ali Saleh,Raelene Endersby,Shek H Yuan,Chirayu Chokshi,Kevin R. Brown,B. Kuzio,Tiina M. Kauppinen,Sheila K. Singh,Suzanne J. Baker,Peter J. McKinnon,Sachin Katyal +11 more
TL;DR: It is shown that RAD51 expression, foci formation and homologous recombination repair activity are unaltered in normal and tumorigenic PTEN-deficient cells and patient samples, underscoring a need to discontinue its use in treating patients with PTEN -deficient tumors that do not otherwise exhibit HRD.
Journal ArticleDOI
Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells
Parvez Vora,Mathieu Seyfrid,Chitra Venugopal,Maleeha Qazi,Sabra K. Salim,Ruth Isserlin,Minomi Subapanditha,Erin O’Farrell,Sujeivan Mahendram,Mohini Singh,David Bakhshinyan,Chirayu Chokshi,Nicole McFarlane,Anna Dvorkin-Gheva,Kevin R. Brown,Naresh Murty,Jason Moffat,Gary D. Bader,Sheila K. Singh +18 more
TL;DR: Light is shed on the association of three genes with CD133-BMI1 circuitry, their importance as downstream effectors of the BMI1 signalling pathway, and their potential as future targets for tackling GBM treatment-resistant cell populations.
Endovascular Thrombectomy for Acute Ischemic Stroke
Jetan H. Badhiwala,Farshad Nassiri,Waleed Alhazzani,Magdy Selim,Forough Farrokhyar,Julian Spears,Abhaya V. Kulkarni,Sheila K. Singh,Abdulrahman Alqahtani,Bram Rochwerg,Mohammad S Al-Shahrani,Naresh Murty,Adel Alhazzani,Blake Yarascavitch,Kesava Reddy,Osama O. Zaidat,Saleh A. Almenawer +16 more
TL;DR: In this article, the authors examined the association between endovascular mechanical thrombectomy and clinical outcomes among patients with acute ischemic stroke, including functional independence at 90 days, functional independence (mRS score, 0-2), angiographic revascularization, symptomatic intracranial hemorrhage within 90 days and all-cause mortality at